Advertisement

Topics

Galmed Pharmaceuticals to Host Post-EASL Key Opinion Leader Call on the Scientific Rationale ...

07:00 EDT 16 Apr 2018 | BioMedReports - Blog

TEL AVIV, Israel, April 16, 2018/PRNewswire/ -- Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company focused on

Read more...

Original Article: Galmed Pharmaceuticals to Host Post-EASL Key Opinion Leader Call on the Scientific Rationale ...

NEXT ARTICLE

More From BioPortfolio on "Galmed Pharmaceuticals to Host Post-EASL Key Opinion Leader Call on the Scientific Rationale ..."

Advertisement
Quick Search
Advertisement
Advertisement